Sana Biotechnology (SANA) Total Assets by Year
Sana Biotechnology, Inc. closed fiscal year 2025 with $416.9M in total assets, $256.0M in total liabilities and $160.9M in shareholder equity. Total assets fell 16.8% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Sana Biotechnology, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SANA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $416.9M-16.8% | $501.0M-11.4% | $565.3M-31.3% | $822.7M-27.2% | $1.1B+54.7% | $730.3M | N/A |
| Total Liabilities | $256.0M+2.2% | $250.5M-9.8% | $277.8M-14.1% | $323.4M-19.3% | $400.9M-65.2% | $1.2B | N/A |
| Total Equity | $160.9M-35.8% | $250.5M-12.9% | $287.5M-42.4% | $499.3M-31.5% | $728.5Mn/m | -$421.2Mn/m | -$142.5M |
SANA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $431.5M+19.3% | $373.6M-16.1% | $416.9M-16.8% | $435.4M-22.2% | $361.6M-41.5% | $445.5M-34.6% | $501.0M-11.4% | $559.4M-11.4% | $618.7M-12.5% | $681.4M-8.8% | $565.3M-31.3% | $631.4M-29.7% |
| Total Liabilities | $277.0M+15.8% | $254.4M+7.6% | $256.0M+2.2% | $240.1M-10.0% | $239.1M-14.3% | $236.4M-22.8% | $250.5M-9.8% | $266.9M+0.5% | $279.0M-20.8% | $306.2M-3.9% | $277.8M-14.1% | $265.6M-20.0% |
| Total Equity | $154.6M+26.1% | $119.2M-43.0% | $160.9M-35.8% | $195.3M-33.2% | $122.6M-63.9% | $209.1M-44.3% | $250.5M-12.9% | $292.5M-20.1% | $339.6M-4.3% | $375.1M-12.4% | $287.5M-42.4% | $365.9M-35.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Sana Biotechnology, Inc. financials
Frequently Asked Questions
Sana Biotechnology, Inc. closed fiscal year 2025 with $416.9M in total assets, $256.0M in total liabilities and $160.9M in shareholder equity.
Sana Biotechnology, Inc. (SANA) total assets fell by 16.8% year over year, from $501.0M to $416.9M in fiscal year 2025.
Sana Biotechnology, Inc. (SANA) reported $431.5M in total assets in Q2 2026. This represents an increase of 19.3% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Sana Biotechnology, Inc. (SANA) reported on that line in every period on record.